| Literature DB >> 33243013 |
Mary C Hidde1, Heather J Leach1,2, Ryan J Marker3, John C Peters4, W Thomas Purcell5,6.
Abstract
INTRODUCTION: Sleep disturbance is the second leading negative side effect reported by cancer survivors, and evidence exists to suggest that exercise may improve sleep for cancer survivors. This study examined changes in sleep following a 3-month, clinic-based exercise program among a diverse group of cancer survivors.Entities:
Keywords: cancer; clinic-based exercise; physical activity; sleep disturbance
Year: 2020 PMID: 33243013 PMCID: PMC7705805 DOI: 10.1177/1534735420975852
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.279
Changes in Sleep From Pre- to Post-Program.
| Question | Pre-program | Post-program | |
|---|---|---|---|
| n, (%) reporting “no” | |||
| “Do you awaken feeling rested” | 48, (51.1) | 39, (41.5) | .08 |
| n, (%) reporting awakening ≥1 time per night | |||
| “How often do you wake up or get up during the night for [variety of reasons]” | 46, (49.5) | 47, (50.5) | .97 |
| n, (%) reporting very poor or poor | |||
| “During the past 4 weeks, how would you rate your sleep quality overall?” | 24, (25.5) | 17, (18.1) | .16 |
Differences Between Participants Who Improved Sleep From Pre- to Post-Program versus Those Who Did Not.
| Improved ≥1 sleep question (N = 48) | No change or worsened in all sleep questions (N = 46) | ||||
|---|---|---|---|---|---|
| N (%) | |||||
| Gender (% male) | 18 (37.5) | 12 (26.1) | .27 | ||
| Race (% white) | 41 (85.4) | 41 (89.1) | .37 | ||
| Cancer diagnosis (% breast) | 17 (35.4) | 17 (37.0) | .81 | ||
| Receiving chemotherapy during program | 14 (29.2) | 14 (30.4) | 1.00 | ||
| Receiving radiation during program | 14 (29.2) | 9 (19.6) | .34 | ||
| Mean (Standard Deviation) | df | ||||
| Age (years) | 55.08 ± 13.17 | 53.39 ± 15.41 | −.58 | 92 | .57 |
| BMI (kg/m2) | 26.77 ± 6.07 | 26.70 ± 6.21 | −.57 | 92 | .96 |
| Exercise sessions attended | 21.74 ± 6.02 | 19.33 ± 6.13 | 1.80 | 80 | .08 |
| Change in grip strength from pre- to post-program (kg) | 0.9 ± 3.55 | 1.66 ± 3.55 | .99 | 86 | .32 |
| Change in 6MWT from pre- to post-program (m) | 44.92 ± 51.40 | 38.68 ± 61.84 | −.49 | 79 | .63 |
| Baseline QOL | 78.69 ± 13.88 | 82.87 ± 13.74 | 1.47 | 92 | .15 |
| Baseline fatigue | 33.90 ± 11.94 | 35.25 ± 11.40 | .56 | 92 | .58 |
Abbreviations: BMI, body mass index; 6MWT, 6-minute walk test; QOL, quality of life.
Fisher’s Exact, Chi-Square, or Independent Samples T-test were utilized to determine differences between groups.
Participant Characteristics (N = 94).
| Mean ± standard deviation | |
|---|---|
| Age | 54.26 ± 14.26 |
| BMI (kg/m2) | 26.73 ± 6.11 |
| Total exercise sessions attended ( | 20.56 ± 6.16 |
| Pre-program grip strength (kg) | 32.71 ± 9.67 |
| Pre-program 6-minute walk test (m) | 647.53 ± 108.76 |
| N (%) | |
| Gender (% male) | 30 (31.9) |
| Race | |
| Asian | 5 (5.3) |
| Black or African American | 3 (3.2) |
| White | 82 (87.2) |
| Cancer diagnosis | |
| Breast | 34 (36.2) |
| Prostate | 7 (7.4) |
| Colorectal | 6 (6.4) |
| Blood or Hematological | 6 (6.4) |
| Lung | 5 (5.3) |
| Brain | 4 (4.3) |
| Esophageal | 4 (4.3) |
| Ovarian | 3 (3.2) |
| Pancreatic | 1 (1.1) |
| Other | 24 (25.5) |
| Receiving | 21 (22.8) |
| Receiving | 16 (17.4) |
| Receiving | 7 (7.6) |
| Surgery completed within previous 6-months | 36 (38.3) |